Consensus recommendations for opioid agonist treatment following the introduction of emergency clinical guidelines in Ireland during the Covid-19 pandemic
A national Delphi study
Dados Bibliográficos
| ID | 14907178 |
|---|---|
| Autores | Louise Durand (0000-0002-5842-6747, Royal College of Surgeons in Ireland), Eamon Keenan (0000-0002-3395-3831, Health Service Executive), Fiona Boland (0000-0003-3228-0046, Royal College of Surgeons in Ireland), Norma Harnedy (0000-0003-4979-3040), Íde Delargy, Mike Scully, Paula Mayock (0000-0002-8377-6466, Trinity College Dublin), William Ebbitt (0000-0001-6584-1511), María Otero Vázquez, Nicola Corrigan (Health Service Executive), Nicki Killeen (0000-0001-6220-1586, Health Service Executive), Muriel Pate (Health Service Executive), Paula Byrne (0000-0002-9034-5154), Gráinne Cousins (0000-0003-2985-7668, Royal College of Surgeons in Ireland, autor correspondente) |
| Ano | 2022 |
| Volume | 106 |
| Páginas | 103768 |
| Data de publicação | 2022-08-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | International Journal of Drug Policy (JOURNAL) |
| Identificadores do periódico | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editora | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2022.103768 |
| PMID | 35738029 |
| OpenAlex | W4282969766 |
| Idioma | EN |
| Citações recebidas | 5 |
| Referências citadas | 43 |
A wide range of stakeholders involved in the delivery and receipt of OAT agreed on 16 clinical guidance statements for inclusion in OAT clinical guidelines as we move beyond the pandemic, rather than reverting to pre-pandemic guidelines. The agreed statements relate to facilitating safe access to OAT with minimal waiting time, supporting patient-centred care to promote health and well-being, and preventing drug overdose. Notably, consensus was not achieved for OAT drug dosage and frequency of urine testing during the stabilisation and maintenance phase of care
2019-20 coronavirus outbreak · Coronavirus disease 2019 (COVID-19 · Delphi method · Disease · Infectious disease (medical specialty · Medical emergency · MEDLINE · Opioid · Pandemic · Political science · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 · Cardiac, Anesthesia and Surgical Outcomes · Computer Science · Delphi Technique in Research · Law · Medicine · Opioid Use Disorder Treatment · Internal Medicine · Virology
Effect of the Covid-19 pandemic on initiations of opioid agonist therapy in Ontario
Impact of guidance issued during Covid-19 to expand access to take-home dosing of opioid agonist treatment (OAT) on OAT prescribing practices in primary care in Ireland
Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of Covid-19 and overdose emergencies
Nurse prescribing of opioid agonist treatment in Ireland
Established Tables and Emergent Huddles
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Collision of the Covid-19 and Addiction Epidemics
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence
Challenges in maintaining treatment services for people who use drugs during the Covid-19 pandemic
Global patterns of opioid use and dependence
Using and Reporting the Delphi Method for Selecting Healthcare Quality Indicators
An Epidemic in the Midst of a Pandemic
Delphi
Impact of the Covid-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada
Pathways between Covid-19 public health responses and increasing overdose risks
Harm reduction in the time of Covid-19
The Covid-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months
How will I get my next week's script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic
Evaluating how has care been affected by the Ontario Covid-19 Opioid Agonist Treatment Guidance
Lacking evidence for the association between frequent urine drug screening and health outcomes of persons on opioid agonist therapy
| Obras citantes distintas | 5 |
|---|---|
| Citações por ano | 1,25 |
| Intervalo de citações | 2022 - 2026 (5) |
| Velocidade de citação | current |
| Altamente citado | Não |
| Tipos de citação | Neutras: 5 |